SERA PROGNOSTICS REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS
SALT LAKE CITY, May 10, 2023 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neona...
Stay updated with breaking news from Sera Prognostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SALT LAKE CITY, May 10, 2023 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neona...
Laurentya Olga and colleagues investigate the relationship between antenatal fetal growth restriction and mid-childhood educational outcomes.
/PRNewswire/ -- The preeclampsia laboratory testing market size is set to grow by USD 785.73 million between 2022 and 2027 and register a CAGR of 8%, according...
Sera Prognostics, Inc. (NASDAQ:SERA – Get Rating) saw a large decline in short interest during the month of April. As of April 15th, there was short interest totalling 182,100 shares, a decline of 24.9% from the March 31st total of 242,600 shares. Based on an average trading volume of 1,310,000 shares, the short-interest ratio is […]
Sera Prognostics, Inc. (NASDAQ:SERA – Get Rating) was the target of a large decrease in short interest in April. As of April 15th, there was short interest totalling 182,100 shares, a decrease of 24.9% from the March 31st total of 242,600 shares. Based on an average daily volume of 1,310,000 shares, the days-to-cover ratio is […]